Lymphoedema is a life-changing condition that affects thousands of Australians, yet it remains widely misunderstood and underdiagnosed. This March, in recognition of Lymphoedema Awareness Month, Cancer Rehabilitation & Lymphatic Solutions is advocating for greater awareness, earlier detection, and access to innovative treatments – because catching it early can make all the difference.
Understanding Lymphoedema: Who is at Risk?
Lymphoedema is a chronic condition that causes swelling due to a compromised lymphatic system. It often develops following cancer treatment, particularly for those recovering from head and neck cancer (HNC) or breast cancer.
- Research suggests that over 50% of HNC patients will develop lymphoedema post-treatment, affecting their ability to swallow, speak, and breathe. Some studies indicate this number could be as high as 75%, highlighting the urgent need for early detection.
- 1 in 5 breast cancer survivors will experience Breast Cancer-Related Lymphoedema (BCRL), which can cause arm and chest swelling, discomfort, and functional limitations. If left untreated, BCRL can become a chronic condition, significantly impacting a person’s quality of life.
Despite these statistics, lymphoedema remains underreported, leaving many patients unaware of their risk until symptoms appear – by which point management becomes more complex.
Why Early Detection is Essential
The key to management lies in early intervention. The earlier it is detected, the better the chances of reducing its severity and long-term impact.
“Too many patients don’t realise they’re at risk until the swelling starts, and by then, it’s much harder to manage,” says Kate Perkins, Cancer Rehabilitation Occupational Therapist. “By integrating early intervention strategies and targeted therapies, we can significantly reduce the impact of lymphoedema on a person’s quality of life.”
CRLS is committed to raising awareness among both the medical profession and the wider community, ensuring that risk factors and symptoms are recognised before they become debilitating.
Advancing Lymphoedema Treatment with Technology
At CRLS, cutting-edge technology is being combined with hands-on care to improve outcomes for patients. One of the most promising developments is OncoLaser™, an innovative protocol co-founded by Kate Perkins and Dr Catherine Norton, CEO of Heal With Laser.
OncoLaser™ utilises MLS® Laser Therapy, a non-invasive treatment that helps:
- Reduce swelling
- Improve circulation
- Support long-term lymphatic health
“OncoLaser™ is changing the way we approach lymphoedema care,” says Perkins. “It’s not just about managing symptoms – it’s about actively improving outcomes, reducing discomfort, and getting people back to living their lives.”
Another breakthrough in early detection is SOZO bioimpedance spectroscopy, a technology that can detect fluid build-up before physical symptoms appear. By identifying lymphoedema in its earliest stages, healthcare providers can intervene sooner, preventing long-term complications and improving patient wellbeing.
How You Can Get Involved
Lymphoedema Awareness Month is an opportunity to advocate for better education, early detection, and improved treatment options. World Lymphoedema Day, held on 6th March, serves as a focal point for action. Too often, lymphoedema isn’t discussed with patients – most people don’t realise they’re at risk until symptoms appear!
Here’s how you can help raise awareness:
- Share information with your community and on social media.
- Encourage early screening for those at risk, especially cancer survivors.
- Support research and innovation in lymphoedema treatment.
- Speak to a healthcare professional if you or a loved one is experiencing swelling, discomfort, or other symptoms.
By spreading awareness and supporting early intervention, we can improve outcomes for those affected and ensure more people receive the care they need before lymphoedema becomes a serious, long-term condition.
For more information about lymphoedema detection and treatment, contact the team at CRLS on (02) 4312 7033.